Axay Tomar: Precision Transfusion and Optimizing Blood Component Therapy in Hematology
Axay Tomar, Associate Professor at Indian Army, shared a post on LinkedIn:
“Blood component therapy is a cornerstone in managing hematological disorders, offering targeted transfusion strategies to optimize patient outcomes.
This chapter explores the role of various blood components, including packed red blood cells (PRBCs), platelets, fresh frozen plasma (FFP), and cryoprecipitate, in treating anemia, thrombocytopenia, and coagulopathies.
PRBC transfusions focus on restrictive strategies to balance oxygen delivery while minimizing risks such as iron overload and transfusion reactions.
Platelet transfusions are essential in thrombocytopenia management, with strict guidelines to prevent transfusion refractoriness and alloimmunization.
FFP plays a critical role in coagulation factor replacement, particularly in disseminated intravascular coagulation (DIC) and massive transfusion protocols.
The chapter also highlights the complex transfusion needs of hematopoietic stem cell transplantation (HSCT) patients, emphasizing the importance of leukoreduction, irradiation, and ABO compatibility.
Special considerations for autoimmune hemolytic anemia (AIHA) and fetal anemia due to Rh isoimmunization are discussed, underlining the challenges in immunohematology.
Advances in blood component modifications, including leukoreduction, pathogen reduction, and extended antigen matching, continue to enhance transfusion safety and efficacy.
The chapter stresses the importance of evidence-based transfusion thresholds, personalized treatment approaches, and emerging innovations to ensure optimal patient care.”
Stay updated with Hemostasis Today.
-
Oct 12, 2026, 17:39Annie Bauzon: Differentiating Direct and Indirect Coombs Tests in Hematology
-
Oct 12, 2026, 17:15Cedric Hermans: Identifying and Diagnosing Hemophilia Carriers and Affected Females
-
Oct 12, 2026, 17:01Bianca Rocca: Evaluating Factor XI Inhibition Lessons from LIBREXIA-ACS
-
Oct 12, 2026, 13:58Francisco Chacón-Lozsán: Catastrophic Antiphospholipid Syndrome A Rapidly Progressive Multiorgan Thrombotic Emergency
-
Oct 12, 2026, 12:50Nawsherwan Mohammad: Study Examines Thrombotic Events in Patients with Polycythemia Vera in Iraq
-
Oct 12, 2026, 12:30Chanakya Nayudu: Looking Beyond Blood Clots – Patient-Reported Outcomes in Antiphospholipid Syndrome
-
Oct 12, 2026, 12:12Jean-Jacques Kiladjian: Improving Treatment Strategies with JAK Inhibitors in Myelofibrosis
-
Oct 12, 2026, 12:04Chloe Homich: AABB Annual Meetings – Building Connections and Advancing Transfusion Medicine
-
Oct 12, 2026, 11:51Daniel Sop: Sickle Cell Research Takes Center Stage at ASCAT 2026